.png)
NEW ORLEANS — For people with type 2 diabetes (T2D) inadequately controlled on submaximal dulaglutide (Trulicity) doses, switching to tirzepatide (Mounjaro) produces significantly greater A1c and weight lowering than does escalating dulaglutide treatment. “Often, when we are with a patient who is not meeting treatment goals...
7200 Powers Ave. #151 Jacksonville, Florida 32217
1-904-729-1091
admin@jacemembers.com
Copyright © 2023 news24. All Rights Reserved
